This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Evaluation of Psychomimetic Properties in Man

John D. Griffith, MD; John Cavanaugh, MD; Joan Held, MA; John A. Oates, MD

Arch Gen Psychiatry. 1972;26(2):97-100.

Abstract
Nine informed volunteers having previous experience with self-administered drugs were given small, frequent orally administered doses of dextroamphetamine sulfate. Within five days following supervised administration, eight subjects experienced a paranoid psychosis which rapidly abated with drug discontinuance. Factors such as sleep deprivation, predrug personality, or drug idiosyncrasy which have been thought crucial in the origin of amphetamine paranoia proved to be insufficient as explanations for the psychosis. Surprisingly, it was found that large long-term doses of dextroamphetamine caused the subjects to feel depressed rather than elated. This suggests that while the short-term effects of dextroamphetamine might be explained as a potentiation of catecholamines, the long-term effects of the drug, including paranoid symptoms, may result from depletion of the central nervous system's stores of catecholamine by dextroamphetamine or one of its metabolites, or both.

Author Affiliations
Nashville, Tenn

From the departments of psychiatry (Dr. Griffith and J. Held), pharmacology (Drs. Griffith, Cavanaugh, and Oates), and medicine (Dr. Oates), Vanderbilt University School of Medicine, Nashville, Tenn. Dr. Griffith is now at the University of California, San Diego, La Jolla.

Footnotes
Accepted for publication Aug 10, 1971.

Reprint requests to Department of Psychiatry, School of Medicine, University of California, San Diego, Box 109, La Jolla 92307 (Dr. Griffith).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine: Implications for Glutamatergic and Dopaminergic Model Psychoses and Cognitive Function
Krystal et al.
Arch Gen Psychiatry 2005;62:985-994.
ABSTRACT | FULL TEXT  

Sources of Diagnostic Uncertainty for Chronically Psychotic Cocaine Abusers
Shaner et al.
Psychiatr. Serv. 1998;49:684-690.
ABSTRACT | FULL TEXT  

An Escalating Dose "Binge" Model of Amphetamine Psychosis: Behavioral and Neurochemical Characteristics
Segal and Kuczenski
J. Neurosci. 1997;17:2551-2566.
ABSTRACT | FULL TEXT  

Drug policy: striking the right balance
Goldstein and Kalant
Science 1990;249:1513-1521.
ABSTRACT  

Is it possible to model psychotic states in animals?
Iversen
J Psychopharmacol 1987;1:154-176.
 

Long-term Pimozide Pretreatment Differentially Affects Behavioral Responses to Dextroamphetamine in Schizophrenia: Further Exploration of the Dopamine Hypothesis of Schizophrenia
van Kammen et al.
Arch Gen Psychiatry 1982;39:275-281.
ABSTRACT  

Multiple Daily Amphetamine Administration: Behavioral and Neurochemical Alterations
SEGAL et al.
Science 1980;207:904-907.
ABSTRACT  

Long-term amphetamine treatment decreases brain serotonin metabolism: implications for theories of schizophrenia
Trulson and Jacobs
Science 1979;205:1295-1297.
ABSTRACT  

Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration
Ellison et al.
Science 1978;201:276-278.
ABSTRACT  

Methylphenidate Hydrochloride Effects on Psychological Tests in Acute Schizophrenic and Nonpsychotic Patients
Janowsky et al.
Arch Gen Psychiatry 1977;34:189-194.
ABSTRACT  

Cardiovascular and Subjective Effects of Intravenous Cocaine Administration in Humans
Fischman et al.
Arch Gen Psychiatry 1976;33:983-989.
ABSTRACT  

Methylphenidate, Dextroamphetamine, and Levamfetamine: Effects on Schizophrenic Symptoms
Janowsky and Davis
Arch Gen Psychiatry 1976;33:304-308.
ABSTRACT  

Drugs, Neurotransmitters, and Schizophrenia
Snyder et al.
Science 1974;184:1243-1253.
 

The Experimental Reproduction of Amphetamine Psychosis
Bell
Arch Gen Psychiatry 1973;29:35-40.
ABSTRACT  

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate
Janowsky et al.
Arch Gen Psychiatry 1973;28:185-191.
ABSTRACT